Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Cancer Surviv. 2017 Nov 20;12(2):234–245. doi: 10.1007/s11764-017-0662-8

Table 1.

Differences in Demographic Characteristics Between Cancer Survivors With (n=85) and Without (n=110) Chemotherapy-Induced Neurotoxicity*

Characteristic No Neurotoxicity
56.4% (n=110)
Neurotoxicity
43.6% (n=85)
Test, p-value

Mean (SD) Mean (SD)

Age (years) 57.3 (11.9) 62.5 (9.8) t = −3.34, p = .001

Education (years) 16.6 (2.5) 15.9 (2.5) t = 1.91, p = .057

% (n) % (n)

Female 86.4 (95) 75.3 (64) FE, p = .062

Married/partnered 65.7 (71) 62.2 (51) FE, p = .649

Lives alone 27.5 (30) 28.6 (24) FE, p = .873

Employed 57.3 (63) 36.5 (31) FE, p = .006

Ethnicity
 White 87.3 (96) 77.6 (66)
 Asian/Pacific Islander 5.5 (6) 4.7 (4) χ2 = 5.16, p = .161
 Black 3.6 (4) 7.1 (6)
 Hispanic/Mixed/Other 3.6 (4) 10.6 (9)

Annual household income
 <$30,000 8.7 (9) 33.3 (27)
 $30,000 – $69,999 20.4 (21) 23.5 (19) U, p <.001
 $70,000 – $99,999 20.4 (21) 11.1 (9)
 >$100,000 50.5 (52) 32.1 (26)

Child care responsibilities 24.1 (26) 6.0 (5) FE, p = .001

Adult care responsibilities 3.8 (4) 0.0 (0) FE, p = .141
*

Chemotherapy-induced neurotoxicity = chemotherapy-induced neuropathy and hearing loss and tinnitus

Abbreviations: FE = Fisher’s Exact test, U = Mann-Whitney U test, SD = standard deviation